September 11, 2009 (FinancialWire) — WaferGen Biosystems, Inc. (OTCBB: WGBS) (Current Market Cap: $62.08 Mil.) said it has closed a series of private placement offerings from June 16 through August 31. The company issued shares of its common stock and warrants to investors in private placement offerings for total gross proceeds of around $6.2 million.

The company issued 5.009 million shares of common stock at $1.25 per share, with 30 percent warrant coverage, or warrants to purchase 1,502,700 shares of common stock, at an exercise price of $2 per whole share.

The warrants have a five-year term and standard broad-based weighted-average anti-dilution protection.

Fremont, California-based WaferGen is engaged in the development, manufacture and sale of systems for gene expression and genotyping for the life science and pharmaceutical industries.

The company is actively developing its SmartChip product for the gene expression and genotyping markets.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.